Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$33.52 - $44.1 $1.65 Million - $2.17 Million
-49,155 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$34.67 - $43.16 $2.38 Million - $2.96 Million
-68,565 Reduced 58.24%
49,155 $1.77 Million
Q2 2020

Aug 14, 2020

SELL
$38.35 - $47.02 $1.39 Million - $1.71 Million
-36,299 Reduced 23.57%
117,720 $4.99 Million
Q1 2020

May 15, 2020

SELL
$41.02 - $59.59 $10.1 Million - $14.6 Million
-245,532 Reduced 61.45%
154,019 $7.05 Million
Q4 2019

Feb 14, 2020

SELL
$52.08 - $62.72 $4.75 Million - $5.72 Million
-91,269 Reduced 18.6%
399,551 $23.6 Million
Q3 2019

Nov 14, 2019

SELL
$49.29 - $58.06 $10.2 Million - $12 Million
-207,244 Reduced 29.69%
490,820 $27.1 Million
Q2 2019

Aug 15, 2019

BUY
$49.34 - $63.49 $719,574 - $925,938
14,584 Added 2.13%
698,064 $38.2 Million
Q1 2019

May 14, 2019

BUY
$59.79 - $74.43 $2.16 Million - $2.69 Million
36,134 Added 5.58%
683,480 $43.2 Million
Q4 2018

Feb 08, 2019

SELL
$65.26 - $85.69 $2.45 Million - $3.21 Million
-37,508 Reduced 5.48%
647,346 $44.2 Million
Q3 2018

Nov 02, 2018

SELL
$60.76 - $73.81 $2.21 Million - $2.69 Million
-36,421 Reduced 5.05%
684,854 $49.9 Million
Q2 2018

Aug 10, 2018

BUY
$59.7 - $68.0 $9.48 Million - $10.8 Million
158,750 Added 28.22%
721,275 $43.3 Million
Q1 2018

May 14, 2018

BUY
$65.43 - $80.27 $5.63 Million - $6.91 Million
86,100 Added 18.07%
562,525 $36.8 Million
Q4 2017

Feb 14, 2018

BUY
$64.48 - $76.95 $7.58 Million - $9.05 Million
117,631 Added 32.79%
476,425 $34.6 Million
Q3 2017

Nov 14, 2017

BUY
$77.22 - $82.74 $2.86 Million - $3.06 Million
37,006 Added 11.5%
358,794 $27.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
321,788
321,788 $25.2 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $7.18B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Foyston, Gordon, & Payne Inc Portfolio

Follow Foyston, Gordon, & Payne Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.